Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer
PHASE1CompletedINTERVENTIONAL
Enrollment
9
Participants
Timeline
Start Date
April 30, 2003
Primary Completion Date
February 28, 2009
Conditions
Lung Cancer
Interventions
DRUG
cisplatin
DRUG
imatinib mesylate
DRUG
irinotecan hydrochloride
Trial Locations (1)
M5G 2M9
Princess Margaret Hospital, Toronto
All Listed Sponsors
collaborator
National Cancer Institute (NCI)
NIH
lead
University Health Network, Toronto
OTHER
NCT00052494 - Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter